Skip to content
PICO Portalanswers from OpenAlex

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis

PaperCitations, authors & open-access status

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis have?

PICO Portalcitation count

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis has 35 citations in the OpenAlex counts PICO Portal stores.

When was Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis published?

PICO Portalyear

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis has 2020 year in the PICO Portal index.

What is the open-access status of Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?

PICO Portaloa status

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis has hybrid oa status in the PICO Portal index.

What is the DOI of Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?

PICO Portaldoi

The DOI for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is on the source record.

What is the PMID of Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?

PICO Portalpmid

The PMID for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is on the source record.

What is the OpenAlex record for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?

PICO Portalopenalex

The OpenAlex for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial